FLUTICASONE PROPIONATE

FLUTICASONE PROPIONATE was reported 131686 times

These side effects are most commonly reported by patients taking FLUTICASONE PROPIONATE:

# Side effect Count
0 DRUG INEFFECTIVE 10581
1 DYSPNOEA 8885
2 FATIGUE 8780
3 HEADACHE 8575
4 NAUSEA 7614
5 PAIN 6633
6 OFF LABEL USE 6558
7 DIARRHOEA 6522
8 COUGH 5939
9 DIZZINESS 5576
10 PNEUMONIA 5132
11 ASTHMA 4903
12 VOMITING 4514
13 ARTHRALGIA 4369
14 RASH 4131
15 MALAISE 4043
16 ANXIETY 3857
17 PRODUCT DOSE OMISSION ISSUE 3857
18 ASTHENIA 3830
19 PRURITUS 3705
20 FALL 3619
21 CONDITION AGGRAVATED 3474
22 SINUSITIS 3442
23 PYREXIA 3417
24 PRODUCT USE IN UNAPPROVED INDICATION 3330
25 WEIGHT DECREASED 3288
26 PAIN IN EXTREMITY 3119
27 INSOMNIA 3035
28 DEATH 3017
29 CONSTIPATION 2985
30 BACK PAIN 2932
31 DEPRESSION 2905
32 EPISTAXIS 2832
33 HYPERTENSION 2741
34 HYPERSENSITIVITY 2656
35 NASOPHARYNGITIS 2650
36 CHEST PAIN 2513
37 CHRONIC KIDNEY DISEASE 2502
38 DRUG HYPERSENSITIVITY 2452
39 FEELING ABNORMAL 2390
40 WEIGHT INCREASED 2378
41 COVID-19 2352
42 URINARY TRACT INFECTION 2338
43 WHEEZING 2335
44 ABDOMINAL PAIN UPPER 2327
45 MUSCLE SPASMS 2237
46 ABDOMINAL PAIN 2227
47 PRODUCT USE ISSUE 2178
48 DECREASED APPETITE 2153
49 SOMNOLENCE 2107
50 ACUTE KIDNEY INJURY 2093
51 PERIPHERAL SWELLING 2091
52 ABDOMINAL DISCOMFORT 2014
53 GASTROOESOPHAGEAL REFLUX DISEASE 2006
54 INJECTION SITE PAIN 1968
55 NASAL CONGESTION 1968
56 RENAL FAILURE 1913
57 INFECTION 1782
58 CHEST DISCOMFORT 1753
59 URTICARIA 1738
60 HYPOAESTHESIA 1735
61 ERYTHEMA 1726
62 GAIT DISTURBANCE 1721
63 BRONCHITIS 1714
64 BLOOD PRESSURE INCREASED 1709
65 MYALGIA 1706
66 HYPOTENSION 1674
67 OROPHARYNGEAL PAIN 1671
68 ANAEMIA 1654
69 PARAESTHESIA 1652
70 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1621
71 TREMOR 1601
72 MEMORY IMPAIRMENT 1595
73 MIGRAINE 1587
74 RHINORRHOEA 1584
75 ALOPECIA 1565
76 PRODUCTIVE COUGH 1548
77 UPPER RESPIRATORY TRACT INFECTION 1538
78 OEDEMA PERIPHERAL 1528
79 VISION BLURRED 1484
80 INFLUENZA 1464
81 DEHYDRATION 1440
82 JOINT SWELLING 1430
83 HYPERHIDROSIS 1417
84 CONFUSIONAL STATE 1416
85 ILLNESS 1411
86 PRODUCT QUALITY ISSUE 1382
87 PALPITATIONS 1380
88 MUSCULAR WEAKNESS 1358
89 DYSPHONIA 1337
90 INCORRECT DOSE ADMINISTERED 1324
91 DYSPEPSIA 1319
92 CONTUSION 1316
93 DRY MOUTH 1307
94 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1295
95 DRUG INTOLERANCE 1290
96 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1262
97 SLEEP DISORDER 1250
98 DRUG INTERACTION 1211
99 HEART RATE INCREASED 1211
100 ATRIAL FIBRILLATION 1207
101 ABDOMINAL DISTENSION 1188
102 HOSPITALISATION 1177
103 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1177
104 SWELLING 1166
105 DRY SKIN 1152
106 RHEUMATOID ARTHRITIS 1135
107 CHILLS 1134
108 PULMONARY EMBOLISM 1121
109 INFUSION RELATED REACTION 1107
110 SEPSIS 1102
111 NEUROPATHY PERIPHERAL 1064
112 ARTHRITIS 1062
113 BLOOD GLUCOSE INCREASED 1057
114 VISUAL IMPAIRMENT 1046
115 INTENTIONAL PRODUCT MISUSE 1045
116 DRUG DOSE OMISSION 1027
117 BALANCE DISORDER 1018
118 DYSPNOEA EXERTIONAL 1010
119 OXYGEN SATURATION DECREASED 1010
120 PSORIASIS 996
121 STRESS 987
122 HEPATIC ENZYME INCREASED 982
123 FLUSHING 981
124 LOSS OF CONSCIOUSNESS 973
125 OEDEMA 971
126 NECK PAIN 966
127 CEREBROVASCULAR ACCIDENT 962
128 EMOTIONAL DISTRESS 956
129 MYOCARDIAL INFARCTION 928
130 GENERAL PHYSICAL HEALTH DETERIORATION 927
131 LUNG DISORDER 903
132 SEIZURE 902
133 OVERDOSE 900
134 DYSPHAGIA 893
135 CARDIAC FAILURE CONGESTIVE 887
136 SWELLING FACE 880
137 SYNCOPE 871
138 GASTROINTESTINAL DISORDER 868
139 THROMBOSIS 867
140 INTENTIONAL PRODUCT USE ISSUE 866
141 FLUID RETENTION 863
142 SEASONAL ALLERGY 858
143 THROAT IRRITATION 855
144 ANOSMIA 850
145 OSTEOARTHRITIS 844
146 INJECTION SITE ERYTHEMA 841
147 WHITE BLOOD CELL COUNT DECREASED 834
148 NO ADVERSE EVENT 822
149 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 815
150 EYE PAIN 810
151 DYSGEUSIA 804
152 PRODUCT DOSE OMISSION 804
153 SINUS DISORDER 801
154 INJURY 791
155 STOMATITIS 788
156 CATARACT 784
157 HAEMOGLOBIN DECREASED 778
158 NASAL DISCOMFORT 778
159 MUSCULOSKELETAL STIFFNESS 776
160 HOT FLUSH 774
161 TACHYCARDIA 773
162 DRY EYE 755
163 DEEP VEIN THROMBOSIS 754
164 EAR INFECTION 754
165 MOBILITY DECREASED 744
166 CARDIAC DISORDER 743
167 CELLULITIS 733
168 RESPIRATORY TRACT INFECTION 729
169 BLOOD CHOLESTEROL INCREASED 727
170 SURGERY 726
171 END STAGE RENAL DISEASE 720
172 SKIN EXFOLIATION 716
173 DIABETES MELLITUS 714
174 OSTEOPOROSIS 714
175 INFLUENZA LIKE ILLNESS 711
176 SLEEP APNOEA SYNDROME 705
177 BLISTER 699
178 HYPOXIA 697
179 THERAPEUTIC RESPONSE UNEXPECTED 696
180 VERTIGO 691
181 GASTROINTESTINAL HAEMORRHAGE 688
182 ADVERSE DRUG REACTION 687
183 PLATELET COUNT DECREASED 682
184 DISCOMFORT 681
185 MUSCULOSKELETAL PAIN 679
186 THROMBOCYTOPENIA 678
187 SUICIDAL IDEATION 677
188 EXPOSURE DURING PREGNANCY 676
189 AMNESIA 674
190 UNEVALUABLE EVENT 673
191 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 670
192 VIRAL INFECTION 666
193 FLATULENCE 664
194 DERMATITIS ATOPIC 656
195 ECZEMA 652
196 HALLUCINATION 648
197 ACCIDENTAL EXPOSURE TO PRODUCT 645
198 RESPIRATORY FAILURE 644
199 PLEURAL EFFUSION 639
200 MATERNAL EXPOSURE DURING PREGNANCY 636
201 TREATMENT FAILURE 626
202 AGEUSIA 623
203 SNEEZING 622
204 HAEMOPTYSIS 620
205 RASH ERYTHEMATOUS 619
206 ARTHROPATHY 613
207 BURNING SENSATION 611
208 EYE IRRITATION 611
209 BLOOD PRESSURE DECREASED 606
210 FIBROMYALGIA 604
211 TINNITUS 597
212 NIGHT SWEATS 596
213 PRODUCT COMPLAINT 591
214 HAEMORRHAGE 586
215 INJECTION SITE BRUISING 586
216 FEELING HOT 583
217 INJECTION SITE SWELLING 583
218 HYPONATRAEMIA 582
219 THERAPY INTERRUPTED 581
220 NEPHROLITHIASIS 576
221 RASH PRURITIC 574
222 DISEASE PROGRESSION 570
223 LOWER RESPIRATORY TRACT INFECTION 570
224 SWOLLEN TONGUE 569
225 CONTRAINDICATED PRODUCT ADMINISTERED 568
226 HERPES ZOSTER 558
227 DEPRESSED MOOD 555
228 BURSITIS 554
229 PSORIATIC ARTHROPATHY 550
230 OBSTRUCTIVE AIRWAYS DISORDER 549
231 RENAL INJURY 549
232 ADVERSE EVENT 547
233 EYE PRURITUS 545
234 INFUSION SITE PAIN 543
235 LETHARGY 543
236 IRRITABILITY 541
237 OCULAR HYPERAEMIA 538
238 INJECTION SITE PRURITUS 532
239 RECTAL HAEMORRHAGE 531
240 ANAPHYLACTIC REACTION 523
241 BONE PAIN 521
242 INFLAMMATION 520
243 RENAL IMPAIRMENT 519
244 ANHEDONIA 518
245 DISTURBANCE IN ATTENTION 518
246 ILL-DEFINED DISORDER 517
247 LACRIMATION INCREASED 517
248 DISEASE RECURRENCE 516
249 DEVICE ISSUE 511
250 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 509
251 NERVOUSNESS 506
252 THERAPEUTIC RESPONSE DECREASED 506
253 CHRONIC SINUSITIS 504
254 HAEMATOCHEZIA 502
255 PRESCRIBED OVERDOSE 501
256 PULMONARY OEDEMA 501
257 OBESITY 493
258 BLOOD CREATININE INCREASED 490
259 FUNGAL INFECTION 487
260 ANGIOEDEMA 486
261 FOOD ALLERGY 485
262 UPPER-AIRWAY COUGH SYNDROME 485
263 IRRITABLE BOWEL SYNDROME 481
264 IMPAIRED QUALITY OF LIFE 479
265 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 477
266 IMMUNODEFICIENCY 468
267 TASTE DISORDER 466
268 POLLAKIURIA 463
269 CARDIAC FAILURE 459
270 NEURALGIA 459
271 TREATMENT NONCOMPLIANCE 458
272 GAIT INABILITY 455
273 TYPE 2 DIABETES MELLITUS 455
274 IMPAIRED HEALING 454
275 NEUTROPENIA 454
276 THERAPY CESSATION 453
277 RESPIRATORY DISORDER 452
278 SKIN DISCOLOURATION 452
279 COGNITIVE DISORDER 451
280 FULL BLOOD COUNT ABNORMAL 450
281 THERAPY NON-RESPONDER 448
282 PANIC ATTACK 446
283 PROCEDURAL PAIN 445
284 TRANSIENT ISCHAEMIC ATTACK 444
285 UNDERDOSE 440
286 INJECTION SITE REACTION 439
287 AGITATION 437
288 EAR PAIN 437
289 PHARMACEUTICAL PRODUCT COMPLAINT 436
290 PRODUCT DOSE OMISSION IN ERROR 436
291 COLITIS 433
292 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 431
293 CORONARY ARTERY DISEASE 426
294 THERAPEUTIC PRODUCT EFFECT DECREASED 426
295 DRUG DEPENDENCE 424
296 ACUTE RESPIRATORY FAILURE 421
297 MACULAR DEGENERATION 420
298 BLOOD POTASSIUM DECREASED 418
299 MULTIPLE SCLEROSIS RELAPSE 418
300 STAPHYLOCOCCAL INFECTION 418
301 RESPIRATORY TRACT CONGESTION 416
302 NEPHROGENIC ANAEMIA 415
303 ORAL CANDIDIASIS 415
304 PRODUCT SUBSTITUTION ISSUE 415
305 HYPOKALAEMIA 412
306 HYPOTHYROIDISM 410
307 SINUS CONGESTION 410
308 GLOSSODYNIA 409
309 MULTIPLE ALLERGIES 408
310 NASAL DRYNESS 406
311 RENAL DISORDER 406
312 LYMPHADENOPATHY 401
313 ASPARTATE AMINOTRANSFERASE INCREASED 399
314 SPEECH DISORDER 399
315 EYE SWELLING 398
316 LIMB INJURY 398
317 FREQUENT BOWEL MOVEMENTS 394
318 ROAD TRAFFIC ACCIDENT 393
319 ALANINE AMINOTRANSFERASE INCREASED 392
320 PAIN IN JAW 392
321 DIVERTICULITIS 388
322 INFUSION SITE ERYTHEMA 386
323 DYSURIA 384
324 CHOLELITHIASIS 378
325 CYSTITIS 378
326 WOUND 378
327 RETCHING 376
328 MIDDLE INSOMNIA 374
329 GASTROENTERITIS VIRAL 372
330 FEBRILE NEUTROPENIA 371
331 HYPOACUSIS 371
332 PARAESTHESIA ORAL 371
333 INTENTIONAL DOSE OMISSION 365
334 PULMONARY HYPERTENSION 364
335 INJECTION SITE HAEMORRHAGE 362
336 NASAL POLYPS 362
337 WHITE BLOOD CELL COUNT INCREASED 362
338 HYPERLIPIDAEMIA 361
339 C-REACTIVE PROTEIN INCREASED 360
340 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 360
341 HEAD INJURY 358
342 CANDIDA INFECTION 353
343 URINARY INCONTINENCE 353
344 SPUTUM DISCOLOURED 351
345 COLITIS ULCERATIVE 350
346 BACK INJURY 349
347 LIVER FUNCTION TEST INCREASED 348
348 RASH MACULAR 348
349 SYSTEMIC LUPUS ERYTHEMATOSUS 348
350 HYPERSOMNIA 347
351 GOUT 346
352 LIP SWELLING 343
353 BACTERIAL INFECTION 342
354 OSTEOPENIA 341
355 CARDIAC ARREST 340
356 PRODUCT DELIVERY MECHANISM ISSUE 340
357 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 339
358 PRODUCT ADMINISTRATION INTERRUPTED 336
359 CROHN^S DISEASE 335
360 ACNE 334
361 DEVICE MALFUNCTION 334
362 HEART RATE DECREASED 332
363 INTERVERTEBRAL DISC PROTRUSION 332
364 THROAT TIGHTNESS 332
365 PULMONARY FIBROSIS 331
366 ORAL PAIN 327
367 BLEPHAROSPASM 325
368 SECRETION DISCHARGE 321
369 ADRENAL INSUFFICIENCY 318
370 PANCREATITIS 318
371 NIGHTMARE 315
372 EAR DISCOMFORT 314
373 INSURANCE ISSUE 314
374 HYPERCHOLESTEROLAEMIA 313
375 EXPIRED PRODUCT ADMINISTERED 312
376 AGGRESSION 310
377 HIATUS HERNIA 310
378 ASCITES 309
379 EYE DISORDER 308
380 DIPLOPIA 305
381 LIMB DISCOMFORT 305
382 PERICARDIAL EFFUSION 304
383 ECONOMIC PROBLEM 303
384 PULMONARY MASS 303
385 RHINITIS 303
386 RED BLOOD CELL COUNT DECREASED 299
387 BLOOD GLUCOSE DECREASED 298
388 INTESTINAL OBSTRUCTION 297
389 GASTRIC DISORDER 296
390 CRYING 293
391 DRUG ADMINISTRATION ERROR 292
392 GASTRITIS 291
393 INFUSION SITE SWELLING 291
394 RHINITIS ALLERGIC 291
395 DRUG EFFECT DECREASED 289
396 FOOT FRACTURE 289
397 MENTAL DISORDER 289
398 ABNORMAL BEHAVIOUR 288
399 RESTLESS LEGS SYNDROME 288
400 SKIN DISORDER 288
401 DYSSTASIA 287
402 RIB FRACTURE 287
403 MENTAL STATUS CHANGES 286
404 PRESYNCOPE 286
405 JOINT RANGE OF MOTION DECREASED 285
406 THERAPEUTIC RESPONSE SHORTENED 285
407 EPILEPSY 284
408 HYPOGLYCAEMIA 282
409 SKIN LESION 282
410 MULTIPLE SCLEROSIS 281
411 FOLLICULITIS 280
412 PRE-EXISTING CONDITION IMPROVED 280
413 DERMATITIS CONTACT 279
414 RESPIRATORY DISTRESS 278
415 POOR QUALITY SLEEP 277
416 DYSARTHRIA 276
417 JOINT INJURY 275
418 ARRHYTHMIA 274
419 DEAFNESS 274
420 PERICARDITIS 274
421 RESPIRATORY SYMPTOM 273
422 ANGER 272
423 BRADYCARDIA 272
424 EMPHYSEMA 271
425 EXTRA DOSE ADMINISTERED 271
426 GLAUCOMA 271
427 MALIGNANT NEOPLASM PROGRESSION 271
428 DISORIENTATION 270
429 BRONCHOSPASM 268
430 PERIPHERAL VENOUS DISEASE 268
431 TUBULOINTERSTITIAL NEPHRITIS 267
432 WOUND INFECTION 267
433 BRONCHIECTASIS 266
434 JOINT STIFFNESS 266
435 HAEMORRHOIDS 265
436 RENAL FAILURE ACUTE 265
437 SCIATICA 265
438 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 264
439 APHONIA 262
440 EXOSTOSIS 262
441 LABORATORY TEST ABNORMAL 262
442 TOXICITY TO VARIOUS AGENTS 262
443 BRAIN FOG 261
444 CYSTIC FIBROSIS 261
445 HAEMATURIA 260
446 DRUG EFFECT INCOMPLETE 259
447 CARPAL TUNNEL SYNDROME 258
448 MEDICATION ERROR 258
449 FEELING JITTERY 257
450 RESTLESSNESS 257
451 URINARY RETENTION 257
452 CLOSTRIDIUM DIFFICILE INFECTION 256
453 LOCALISED INFECTION 254
454 VITAMIN D DEFICIENCY 253
455 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 252
456 SYNOVITIS 251
457 DYSKINESIA 250
458 COELIAC DISEASE 249
459 HIP FRACTURE 249
460 NEOPLASM MALIGNANT 249
461 ROTATOR CUFF SYNDROME 249
462 CUSHING^S SYNDROME 248
463 MOOD SWINGS 248
464 MUSCULOSKELETAL CHEST PAIN 248
465 HEAD DISCOMFORT 247
466 SINUS HEADACHE 245
467 CONVULSION 244
468 VASCULITIS 244
469 INJECTION SITE RASH 243
470 INTERVERTEBRAL DISC DEGENERATION 243
471 HYPERGLYCAEMIA 242
472 LIVER DISORDER 242
473 PNEUMOTHORAX 242
474 BREAST CANCER STAGE III 241
475 FEMUR FRACTURE 241
476 NODULE 241
477 SKIN ULCER 241
478 LARYNGITIS 240
479 CONJUNCTIVITIS 238
480 BONE DENSITY DECREASED 237
481 HYPOPHAGIA 237
482 INFUSION SITE REACTION 237
483 SKIN FISSURES 237
484 INJECTION SITE MASS 236
485 EXPOSURE VIA SKIN CONTACT 235
486 ORAL HERPES 235
487 PULMONARY CONGESTION 235
488 FULL BLOOD COUNT DECREASED 234
489 IMPAIRED GASTRIC EMPTYING 234
490 IRON DEFICIENCY ANAEMIA 234
491 SKIN LACERATION 234
492 DRUG WITHDRAWAL SYNDROME 233
493 FACIAL PAIN 233
494 WITHDRAWAL SYNDROME 233
495 HEART RATE IRREGULAR 232
496 KNEE ARTHROPLASTY 232
497 BLINDNESS 231
498 PANCYTOPENIA 231
499 GALLBLADDER DISORDER 230
500 SEPTIC SHOCK 230
501 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 228
502 FACET JOINT SYNDROME 228
503 MOOD ALTERED 228
504 BACK DISORDER 227
505 TOOTH DISORDER 227
506 CHOKING 226
507 BLOOD PRESSURE ABNORMAL 225
508 BLOOD SODIUM DECREASED 225
509 FEELING COLD 225
510 SKIN BURNING SENSATION 225
511 FEMALE GENITAL TRACT FISTULA 223
512 HELICOBACTER INFECTION 223
513 PAROSMIA 223
514 PULMONARY ARTERIAL HYPERTENSION 223
515 SPINAL OSTEOARTHRITIS 222
516 ULCER 222
517 DEVICE DISLOCATION 220
518 EOSINOPHIL COUNT INCREASED 218
519 PRODUCT STORAGE ERROR 218
520 HAEMATOCRIT DECREASED 217
521 LIVER FUNCTION TEST ABNORMAL 217
522 PRODUCT PRESCRIBING ERROR 217
523 DEVICE BREAKAGE 216
524 HYPERPARATHYROIDISM SECONDARY 216
525 INFUSION SITE HAEMORRHAGE 216
526 INTERSTITIAL LUNG DISEASE 216
527 EMOTIONAL DISORDER 215
528 RHINALGIA 215
529 THYROID DISORDER 215
530 BLOOD ALKALINE PHOSPHATASE INCREASED 214
531 UPPER LIMB FRACTURE 213
532 BLOOD PRESSURE FLUCTUATION 212
533 MULTIPLE ORGAN DYSFUNCTION SYNDROME 212
534 PARANASAL SINUS DISCOMFORT 212
535 PNEUMONIA ASPIRATION 212
536 RADICULOPATHY 212
537 ABNORMAL DREAMS 211
538 ACUTE MYOCARDIAL INFARCTION 211
539 MUSCLE TWITCHING 211
540 TOOTH INFECTION 211
541 VAGINAL DISCHARGE 211
542 APHASIA 210
543 ATELECTASIS 210
544 LUNG INFECTION 210
545 DELIRIUM 209
546 BREAST CANCER 208
547 DRY THROAT 207
548 EATING DISORDER 207
549 HERNIA 207
550 ORTHOSTATIC HYPOTENSION 206
551 TOOTHACHE 206
552 HYPERKALAEMIA 205
553 REBOUND ACID HYPERSECRETION 204
554 BLOOD COUNT ABNORMAL 203
555 DUODENAL ULCER PERFORATION 203
556 LOWER LIMB FRACTURE 203
557 PNEUMONITIS 203
558 HEPATIC STEATOSIS 202
559 TEMPERATURE REGULATION DISORDER 202
560 FOETAL DEATH 201
561 DRUG ABUSE 200
562 PHOTOPHOBIA 200
563 PLASMA CELL MYELOMA 200
564 EXERCISE TOLERANCE DECREASED 198
565 MOVEMENT DISORDER 198
566 NASAL OEDEMA 198
567 ACCIDENTAL OVERDOSE 197
568 KIDNEY INFECTION 197
569 LEUKOCYTOSIS 197
570 PEMPHIGUS 197
571 BONE DISORDER 196
572 RASH PAPULAR 196
573 ANKLE FRACTURE 195
574 DERMATITIS 195
575 POST PROCEDURAL COMPLICATION 195
576 DEVICE LEAKAGE 194
577 FEAR 194
578 HAEMATOMA 194
579 MUSCLE INJURY 194
580 MYASTHENIA GRAVIS 194
581 FAECES DISCOLOURED 192
582 FLUID OVERLOAD 192
583 MUSCULOSKELETAL DISCOMFORT 192
584 APPENDICITIS 191
585 EYE INFECTION 191
586 HYPOPHOSPHATAEMIA 191
587 INCORRECT PRODUCT ADMINISTRATION DURATION 191
588 LIP DRY 191
589 OCULAR DISCOMFORT 191
590 BLOOD TEST ABNORMAL 190
591 DECREASED ACTIVITY 190
592 HEREDITARY ANGIOEDEMA 190
593 TRICUSPID VALVE INCOMPETENCE 190
594 ANGINA PECTORIS 188
595 FEEDING DISORDER 188
596 MALNUTRITION 188
597 PRESCRIBED UNDERDOSE 188
598 LIGAMENT SPRAIN 187
599 BLOOD URINE PRESENT 186
600 DISABILITY 186
601 INCORRECT DRUG ADMINISTRATION DURATION 186
602 SKIN IRRITATION 186
603 GASTRIC ULCER 185
604 INITIAL INSOMNIA 185
605 INJECTION SITE URTICARIA 185
606 PHARYNGITIS STREPTOCOCCAL 185
607 CARDIOGENIC SHOCK 184
608 LEUKOPENIA 183
609 PHARYNGITIS 183
610 LUNG NEOPLASM MALIGNANT 182
611 ONYCHOMADESIS 182
612 SUICIDE ATTEMPT 182
613 THIRST 182
614 FORCED EXPIRATORY VOLUME DECREASED 181
615 TOOTH ABSCESS 181
616 COVID-19 PNEUMONIA 179
617 INCREASED UPPER AIRWAY SECRETION 179
618 LIVER INJURY 179
619 NOCTURIA 179
620 TENDERNESS 179
621 DRUG DOSE OMISSION BY DEVICE 178
622 PHARYNGEAL OEDEMA 178
623 DIVERTICULUM 177
624 NAIL DISORDER 177
625 UNRESPONSIVE TO STIMULI 177
626 BASAL CELL CARCINOMA 176
627 DEVICE DELIVERY SYSTEM ISSUE 176
628 HYPOAESTHESIA ORAL 176
629 BLOOD IRON DECREASED 175
630 NEUTROPHIL COUNT DECREASED 175
631 INFUSION SITE PRURITUS 174
632 PAIN OF SKIN 174
633 TENDONITIS 174
634 THINKING ABNORMAL 174
635 DIABETES MELLITUS INADEQUATE CONTROL 173
636 INFUSION SITE DISCHARGE 173
637 OSTEONECROSIS 173
638 PROSTATE CANCER 173
639 ARTERIOSCLEROSIS 172
640 CHROMATURIA 172
641 HAEMATEMESIS 172
642 LIVE BIRTH 172
643 PROCTITIS 172
644 SPINAL FRACTURE 172
645 WEIGHT FLUCTUATION 171
646 ENCEPHALOPATHY 170
647 WRONG TECHNIQUE IN DRUG USAGE PROCESS 170
648 MICTURITION URGENCY 169
649 OROPHARYNGEAL DISCOMFORT 169
650 MOUTH ULCERATION 168
651 DRUG EFFECT LESS THAN EXPECTED 167
652 INCREASED TENDENCY TO BRUISE 167
653 NEEDLE ISSUE 167
654 BLOOD TRIGLYCERIDES INCREASED 166
655 MITRAL VALVE INCOMPETENCE 165
656 VISUAL ACUITY REDUCED 165
657 DEMENTIA 164
658 EOSINOPHILIA 164
659 IMPAIRED WORK ABILITY 164
660 INTERNATIONAL NORMALISED RATIO INCREASED 164
661 PULMONARY FUNCTION TEST DECREASED 163
662 RHEUMATIC FEVER 163
663 ACTIVITIES OF DAILY LIVING IMPAIRED 162
664 BREATH SOUNDS ABNORMAL 162
665 EYE HAEMORRHAGE 162
666 IRON DEFICIENCY 162
667 SCAR 162
668 SINUS TACHYCARDIA 161
669 ABDOMINAL PAIN LOWER 160
670 ERECTILE DYSFUNCTION 160
671 GLYCOSYLATED HAEMOGLOBIN INCREASED 160
672 INCREASED APPETITE 160
673 OBSTRUCTIVE SLEEP APNOEA SYNDROME 160
674 VAGINAL FLATULENCE 160
675 BODY TEMPERATURE INCREASED 159
676 HAIR COLOUR CHANGES 159
677 MUSCLE STRAIN 159
678 PRURITUS GENERALISED 159
679 MUSCLE TIGHTNESS 158
680 PSYCHOMOTOR HYPERACTIVITY 158
681 MUSCULOSKELETAL DISORDER 157
682 PRODUCT ADMINISTRATION ERROR 157
683 PSEUDOMONAS INFECTION 157
684 WRIST FRACTURE 157
685 ADRENAL SUPPRESSION 156
686 ASPIRATION 156
687 BLOOD BILIRUBIN INCREASED 156
688 HAIR TEXTURE ABNORMAL 156
689 PHOTOSENSITIVITY REACTION 156
690 RESPIRATORY SYNCYTIAL VIRUS INFECTION 156
691 ARTERIOSCLEROSIS CORONARY ARTERY 155
692 BLOOD UREA INCREASED 155
693 PRODUCT USE COMPLAINT 155
694 RASH GENERALISED 155
695 SPUTUM INCREASED 155
696 VENTRICULAR FIBRILLATION 155
697 EYE DISCHARGE 154
698 OSTEOMYELITIS 154
699 QUALITY OF LIFE DECREASED 154
700 UPPER GASTROINTESTINAL HAEMORRHAGE 154
701 VAGINAL HAEMORRHAGE 154
702 HOSPICE CARE 153
703 SCAB 153
704 SKIN HAEMORRHAGE 153
705 SMALL INTESTINAL OBSTRUCTION 153
706 BLOOD PRESSURE SYSTOLIC INCREASED 152
707 ELECTROCARDIOGRAM QT PROLONGED 152
708 MENTAL IMPAIRMENT 152
709 COLD SWEAT 151
710 HEPATIC CIRRHOSIS 151
711 SPINAL OPERATION 151
712 BLOOD POTASSIUM INCREASED 150
713 CARDIOMEGALY 150
714 HAND DEFORMITY 150
715 SENSORY DISTURBANCE 150
716 ERUCTATION 149
717 ORAL DISCOMFORT 149
718 DENTAL CARIES 148
719 PRODUCT PACKAGE ASSOCIATED INJURY 148
720 COAGULOPATHY 147
721 IMMUNE SYSTEM DISORDER 147
722 NERVOUS SYSTEM DISORDER 147
723 RENAL TUBULAR NECROSIS 147
724 RESPIRATORY DEPRESSION 147
725 SENSATION OF FOREIGN BODY 147
726 BLOOD IMMUNOGLOBULIN E INCREASED 146
727 PALLOR 146
728 PSYCHOTIC DISORDER 146
729 RED BLOOD CELL SEDIMENTATION RATE INCREASED 146
730 SEDATION 146
731 SKIN CANCER 146
732 DEPRESSED LEVEL OF CONSCIOUSNESS 145
733 DEVICE USE ERROR 145
734 NEPHROPATHY 145
735 PARKINSON^S DISEASE 145
736 SARS-COV-2 TEST POSITIVE 145
737 SKIN INFECTION 145
738 TROPONIN INCREASED 145
739 BODY HEIGHT DECREASED 144
740 CEREBRAL HAEMORRHAGE 144
741 HIP ARTHROPLASTY 144
742 OESOPHAGITIS 144
743 TENDON RUPTURE 144
744 BLOOD CALCIUM INCREASED 143
745 CHOLECYSTECTOMY 143
746 DIZZINESS POSTURAL 142
747 HYPERPHOSPHATAEMIA 142
748 NASAL DISORDER 142
749 VENTRICULAR TACHYCARDIA 142
750 CARDIOMYOPATHY 141
751 PELVIC PAIN 141
752 PHARYNGEAL SWELLING 141
753 SNORING 141
754 VENTRICULAR EXTRASYSTOLES 141
755 CARDIO-RESPIRATORY ARREST 140
756 CLOSTRIDIUM DIFFICILE COLITIS 140
757 HYPERVOLAEMIA 140
758 MADAROSIS 140
759 PULMONARY THROMBOSIS 140
760 RHABDOMYOLYSIS 140
761 VITAMIN D DECREASED 140
762 DEVICE FAILURE 139
763 BLOOD PHOSPHORUS INCREASED 138
764 BLOOD URIC ACID INCREASED 138
765 PRODUCT PRESCRIBING ISSUE 138
766 TEMPERATURE INTOLERANCE 138
767 CONCUSSION 137
768 RALES 137
769 CYST 136
770 PERIPHERAL COLDNESS 136
771 PNEUMONIA BACTERIAL 136
772 TRANSAMINASES INCREASED 136
773 APPENDICOLITH 135
774 ARTHROPOD BITE 135
775 CARDIAC MURMUR 135
776 HYSTERECTOMY 135
777 PARANOIA 135
778 PRODUCT ODOUR ABNORMAL 135
779 BLADDER DISORDER 134
780 FLANK PAIN 134
781 HALLUCINATION, VISUAL 134
782 HUNGER 134
783 TOOTH FRACTURE 134
784 ATRIAL FLUTTER 133
785 BLOOD MAGNESIUM DECREASED 133
786 PLATELET COUNT INCREASED 133
787 MUSCLE ATROPHY 132
788 GASTROENTERITIS 131
789 HEPATIC FAILURE 131
790 PARANASAL SINUS HYPERSECRETION 131
791 TOOTH LOSS 131
792 DRUG-INDUCED LIVER INJURY 130
793 NERVE COMPRESSION 130
794 RENAL CYST 129
795 POLYP 128
796 HEMIPARESIS 127
797 INFUSION SITE EXTRAVASATION 127
798 MAJOR DEPRESSION 127
799 PRODUCT DISTRIBUTION ISSUE 127
800 CHOLECYSTITIS CHRONIC 126
801 INFUSION SITE BRUISING 126
802 ABASIA 125
803 BENIGN PROSTATIC HYPERPLASIA 125
804 BIPOLAR DISORDER 125
805 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 125
806 CONJUNCTIVITIS ALLERGIC 125
807 OBSESSIVE-COMPULSIVE DISORDER 125
808 RESPIRATION ABNORMAL 125
809 ANAL INCONTINENCE 124
810 ESSENTIAL HYPERTENSION 124
811 INCONTINENCE 124
812 PANCREATITIS ACUTE 124
813 SUPRAVENTRICULAR TACHYCARDIA 124
814 DEVICE DIFFICULT TO USE 123
815 GLUCOSE TOLERANCE IMPAIRED 123
816 LOCAL SWELLING 123
817 NERVE INJURY 123
818 SKIN SWELLING 123
819 VITREOUS FLOATERS 123
820 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 122
821 LACERATION 122
822 LYMPHOCYTE COUNT DECREASED 122
823 ABSCESS 121
824 AUTOIMMUNE DISORDER 121
825 INCORRECT ROUTE OF DRUG ADMINISTRATION 121
826 PRODUCT AVAILABILITY ISSUE 120
827 CUSHINGOID 119
828 NASAL ULCER 119
829 SINUS OPERATION 119
830 COMPLICATION ASSOCIATED WITH DEVICE 118
831 FOOT DEFORMITY 118
832 GASTROINTESTINAL INFECTION 118
833 JOINT DISLOCATION 118
834 METABOLIC ACIDOSIS 118
835 MUSCLE SPASTICITY 118
836 NEUROLOGICAL SYMPTOM 118
837 POST-TRAUMATIC STRESS DISORDER 118
838 ACUTE SINUSITIS 117
839 BLOOD CALCIUM DECREASED 117
840 CORONARY ARTERY OCCLUSION 117
841 KNEE OPERATION 117
842 MASS 117
843 MITE ALLERGY 117
844 NEOPLASM PROGRESSION 117
845 ASTHMATIC CRISIS 116
846 GLOMERULAR FILTRATION RATE DECREASED 116
847 POOR VENOUS ACCESS 116
848 PRODUCT PREPARATION ERROR 116
849 SOMNAMBULISM 116
850 RIGHT VENTRICULAR FAILURE 114
851 CYANOSIS 113
852 HAIR DISORDER 113
853 INTRAOCULAR PRESSURE INCREASED 113
854 MULTIPLE FRACTURES 113
855 SCRATCH 113
856 DUST ALLERGY 112
857 SPINAL DISORDER 112
858 CARDIAC FLUTTER 111
859 DEVICE RELATED INFECTION 111
860 MYCOTIC ALLERGY 111
861 INCORRECT DOSE ADMINISTERED BY DEVICE 110
862 LACTIC ACIDOSIS 110
863 MENISCUS INJURY 110
864 NEURITIS 110
865 BLOOD PRESSURE INADEQUATELY CONTROLLED 109
866 DRUG THERAPY 109
867 GINGIVAL BLEEDING 109
868 HEPATITIS 109
869 MELAENA 109
870 RHINOVIRUS INFECTION 109
871 TARDIVE DYSKINESIA 109
872 TRANSFUSION 109
873 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 108
874 MIDDLE EAR EFFUSION 108
875 PRODUCT PHYSICAL ISSUE 108
876 SINUS PAIN 108
877 DEVICE OCCLUSION 107
878 INJECTION SITE WARMTH 107
879 PLANTAR FASCIITIS 107
880 EJECTION FRACTION DECREASED 106
881 OSTEONECROSIS OF JAW 106
882 PHARYNGOLARYNGEAL PAIN 106
883 PRODUCT PACKAGING QUANTITY ISSUE 106
884 CARDIOVASCULAR DISORDER 105
885 DIASTOLIC DYSFUNCTION 105
886 GASTROINTESTINAL PAIN 105
887 JAUNDICE 105
888 LUNG INFILTRATION 105
889 OVERWEIGHT 105
890 CANDIDIASIS 104
891 EAR DISORDER 104
892 ELECTROLYTE IMBALANCE 104
893 RESPIRATORY ARREST 104
894 TOOTH EXTRACTION 104
895 ORAL DISORDER 103
896 PSYCHOLOGICAL TRAUMA 103
897 ANALGESIC THERAPY 102
898 APPETITE DISORDER 102
899 BLOOD CREATINE PHOSPHOKINASE INCREASED 102
900 DRUG EXPOSURE DURING PREGNANCY 102
901 GINGIVAL PAIN 102
902 LYMPHOEDEMA 102
903 PULMONARY ALVEOLAR HAEMORRHAGE 102
904 ANAPHYLACTIC SHOCK 101
905 DEVICE DEFECTIVE 101
906 DEVICE USE ISSUE 101
907 HAND FRACTURE 100
908 HYPERTHYROIDISM 100
909 HYPOCALCAEMIA 100
910 INFUSION SITE INFECTION 100
911 MALIGNANT MELANOMA 100
912 OVERLAP SYNDROME 100
913 SCOLIOSIS 100
914 SLUGGISHNESS 100
915 SPINAL COMPRESSION FRACTURE 100
916 DEVICE INFUSION ISSUE 99
917 HEPATOMEGALY 99
918 RESPIRATORY RATE INCREASED 99
919 SPLENOMEGALY 99
920 SQUAMOUS CELL CARCINOMA 99
921 ABORTION SPONTANEOUS 98
922 BRAIN NATRIURETIC PEPTIDE INCREASED 98
923 FRUSTRATION TOLERANCE DECREASED 98
924 HYPOMAGNESAEMIA 98
925 PRODUCT TASTE ABNORMAL 98
926 AORTIC STENOSIS 97
927 CHOLECYSTITIS 97
928 GROIN PAIN 97
929 HAEMOGLOBIN INCREASED 97
930 MANIA 97
931 COORDINATION ABNORMAL 96
932 DECREASED IMMUNE RESPONSIVENESS 96
933 DELUSION 96
934 GRIP STRENGTH DECREASED 96
935 OVARIAN CYST 96
936 POST PROCEDURAL INFECTION 96
937 BLOOD ALBUMIN DECREASED 95
938 COLON CANCER 95
939 HYPOKINESIA 95
940 SLEEP TERROR 95
941 BLOOD GLUCOSE ABNORMAL 94
942 FOETAL EXPOSURE DURING PREGNANCY 94
943 IMPAIRED DRIVING ABILITY 94
944 INTENTIONAL OVERDOSE 94
945 PRODUCT DISPENSING ERROR 94
946 ROSACEA 94
947 STEVENS-JOHNSON SYNDROME 94
948 APATHY 93
949 DECREASED INTEREST 93
950 FRACTURE 93
951 INJECTION SITE DISCOLOURATION 93
952 AFFECTIVE DISORDER 92
953 INTERNAL HAEMORRHAGE 92
954 NASAL SEPTUM DEVIATION 92
955 SPINAL COLUMN STENOSIS 92
956 COMA 91
957 DEVICE EXPULSION 91
958 ELECTROCARDIOGRAM ABNORMAL 91
959 HALLUCINATION, AUDITORY 91
960 ODYNOPHAGIA 91
961 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 91
962 TACHYPNOEA 91
963 CHOKING SENSATION 90
964 FEELING DRUNK 90
965 RECALLED PRODUCT ADMINISTERED 90
966 SLEEP DISORDER THERAPY 90
967 APPLICATION SITE PAIN 89
968 DISLOCATION OF VERTEBRA 89
969 LYMPHOPENIA 89
970 ONYCHOCLASIS 89
971 SPINAL PAIN 89
972 GENERALISED OEDEMA 88
973 LARGE INTESTINE POLYP 88
974 NORMOCHROMIC NORMOCYTIC ANAEMIA 88
975 PULMONARY VASCULITIS 88
976 RETINITIS 88
977 TENSION HEADACHE 88
978 URINE OUTPUT DECREASED 88
979 VIRAL UPPER RESPIRATORY TRACT INFECTION 88
980 APPLICATION SITE ERYTHEMA 87
981 IMMUNOSUPPRESSION 87
982 NASAL DISCHARGE DISCOLOURATION 87
983 PREGNANCY 87
984 PROTEINURIA 87
985 INCORRECT DRUG ADMINISTRATION RATE 86
986 NASAL INFLAMMATION 86
987 OBSTRUCTION 86
988 ONYCHOMYCOSIS 86
989 SKIN ABRASION 86
990 SWELLING OF EYELID 86
991 UROSEPSIS 86
992 APPLICATION SITE PRURITUS 85
993 HORDEOLUM 85
994 PERSONALITY CHANGE 85
995 RED CELL DISTRIBUTION WIDTH INCREASED 85
996 VASCULAR DEVICE INFECTION 85
997 BRONCHIAL HYPERREACTIVITY 84
998 ENURESIS 84
999 EUPHORIC MOOD 84